Skip to content
OpenSampling

2015 · Diabetes technology & therapeutics · paywalled

Use of Dried Capillary Blood Sampling for Islet Autoantibody Screening in Relatives: A Feasibility Study

Bingley et al.

The finding, in our words

Dried capillary blood spot screening correctly identified 95.5% of relatives with multiple islet autoantibodies and 98.6% of those without, and 60% of participants favoured initial home fingerstick screening with clinic visits only if autoantibodies were found.

A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.

Labels

  1. 2026

    Patient-centric capillary dried blood spot sampling for tacrolimus and creatinine monitoring in clinical practice

    The study found that quantitative dried blood spot sampling provided high clinical agreement for tacrolimus and creatinine monitoring, with patients rating the self-collection devices as user-friendly. These results support the feasibility of decentralised therapeutic drug monitoring for immunosuppressants.

    De Baets et al., Clinical chemistry and laboratory medicine (paywalled) · source ↗

    • blood
    • dried
    • capillary
    • dbs
    • qdbs
    • self-collection
    • venous-agreement
    • acceptability
    • tdm
    • immunosuppressants
  2. 2026

    From venipuncture to self-sampling dried blood spots: a shift in monitoring testosterone levels

    Home DBS sampling gave testosterone results that agreed well with venous blood in men on intramuscular testosterone undecanoate, but showed falsely high values in those using topical gel, likely from skin contamination. Patients preferred home collection for its convenience, suggesting DBS is viable for decentralised monitoring of injectable testosterone if patients are taught proper technique.

    Olthof et al., Clinical chemistry and laboratory medicine (paywalled) · source ↗

    • blood
    • dried
    • capillary
    • dbs
    • self-collection
    • validation
    • venous-agreement
    • acceptability
    • fertility
    • hormones
    • tdm
  3. 2025

    Establishing the performance and acceptability of dried blood spot sampling to screen for islet-specific autoantibodies

    Dried blood spot sampling matched venous serum performance for islet autoantibody detection and was considered minimally invasive and convenient by parents and stakeholders, supporting its use for decentralised screening in home or community settings.

    Faustini et al., Diabetic medicine : a journal of the British Diabetic Association · source ↗

    • blood
    • dried
    • capillary
    • dbs
    • self-collection
    • validation
    • venous-agreement
    • acceptability
    • pediatric
  4. 2024

    Remote dried blood spot collection for inflammatory markers in older adults is feasible, reliable, and valid

    Older adults achieved 98% adherence when self-collecting dried blood spots at home for inflammatory markers, with 97% of samples yielding valid results. Test-retest reliability was good (ICCs 0.70–0.76) and correlation with venous blood was strong (r=0.60–0.99), demonstrating that remote capillary sampling is a feasible and valid method for decentralised assessment of inflammation in older adults.

    Reed et al., Brain, behavior, and immunity (paywalled) · source ↗

    • venous-agreement
    • acceptability
    • blood
    • dbs
    • self-collection
    • dried
    • capillary
    • validation
    • biomarkers
  5. 2023

    VAMS and parallel-reaction-monitoring mass spectrometry for tacrolimus trough measurements at home in paediatric heart-transplant patients

    VAMS microsampling found no significant difference from venous blood for tacrolimus in paediatric patients; samples were stable for 14 days, with average difference between paired at-home samples of 0.12 ± 0.94 ng/mL.

    Zhao et al., J. Mass Spectrometry and Advances in the Clinical Lab · source ↗

    • vams
    • venous-agreement
    • acceptability
    • blood
    • dbs
    • tdm
    • self-collection
    • dried
    • capillary
    • pediatric
    • immunosuppressants
    • validation